Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 8/20 | 0.47 |
| ▸ | OGA | O60502 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 7/20 | 0.45 |
| ▸ | CA12 | O43570 | 6/20 | 0.45 |
| ▸ | CA4 | P22748 | 4/20 | 0.45 |
| ▸ | CA5A | P35218 | 4/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.45 |
| ▸ | CA7 | P43166 | 3/20 | 0.45 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.41 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4619733 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL313683 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL13928976 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL9616862 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL6230386 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL3972810 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL4619592 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL8089407 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL314060 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA | |
| SCHEMBL1686174 | 1.00 | CYP2D6 (0.51) | CYP2D6THRBHSD17B10CA2OGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4914195-A | Process for preparing N-acetylneuraminic acid derivatives | MECT CORPORATION (JP) | 1990-04-03 | — | — | US | claimed |
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2024-02-29 | — | — | US | disclosed |
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2024-02-29 | — | — | US | disclosed |
| EP-3851447-B1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2023-09-06 | — | — | EP | disclosed |
| US-20210401947-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-12-30 | — | — | US | disclosed |
| US-20210401946-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-12-30 | — | — | US | disclosed |
| US-20210386693-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2021-12-16 | — | — | US | disclosed |
| US-20210386693-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2021-12-16 | — | — | US | disclosed |
| US-11090364-B2 | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein | SANOFI (FR) | 2021-08-17 | — | — | US | disclosed |
| EP-2862581-B1 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | BHI LP (CA) | 2021-08-11 | — | — | EP | disclosed |
| WO-1991003174-A1 | PROCESS FOR OBTAINING AROMA COMPONENTS AND AROMAS FROM THEIR PRECURSORS OF A GLYCOSIDIC NATURE, AND AROMA COMPONENTS AND AROMAS THEREBY OBTAINED | GIST-BROCADES N.V. (NL) | 1991-03-21 | — | — | WO | disclosed |
| EP-0416713-A1 | Process for obtaining aroma components and aromas from their precursors of a glycosidic nature, and aroma components and aromas thereby obtained | GIST-BROCADES N.V. (NL) | 1991-03-13 | — | — | EP | disclosed |
| EP-0243429-B1 | D-LUCIFERIN DERIVATIVES AND THEIR USE | Geiger, Reinhard, Dr. (DE) | 1991-01-23 | — | — | EP | disclosed |
| EP-0263027-B1 | GLYCOSIDATION CATALYST AND PROCESS FOR PREPARING GLYCOSIDE DERIVATIVES | NIPPON FINE CHEMICAL CO., LTD. (JP) | 1990-11-14 | — | — | EP | disclosed |
| US-4874852-A | Glycosidation catalust and process for preparing glycoside derivatives | NIPPON FINE CHEMICAL CO., LTD. (JP) | 1989-10-17 | — | — | US | disclosed |
| EP-0332281-A1 | Process for obtaining aroma components and aromas from their precursors of a glycosidic nature | GIST-BROCADES N.V. (NL) | 1989-09-13 | — | — | EP | disclosed |
| EP-0263027-A1 | Glycosidation catalyst and process for preparing glycoside derivatives | NIPPON FINE CHEMICAL CO., LTD. (JP) | 1988-04-06 | — | — | EP | disclosed |
| EP-0243429-A1 | D-LUCIFERIN DERIVATIVES AND THEIR USE. | GEIGER REINHARD DR (DE) | 1987-11-04 | — | — | EP | disclosed |
| WO-1987002667-A1 | D-LUCIFERIN DERIVATIVES AND THEIR USE | GEIGER REINHARD (DE) | 1987-05-07 | — | — | WO | disclosed |
| US-4447600-A | IMMUNOSUPPRESSIVE AGENTS | KANTO ISHI PHARMACEUTICAL CO., LTD. (JP) | 1984-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11090364-B2 | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein | GPR119, SLC2A8, SLC2A4 | CYP2D6 1736/4885THRB 974/4885HSD17B10 2189/4885 |
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | APP, PSEN1, PSEN2 | CYP2D6 637/4885THRB 4622/4885HSD17B10 1477/4885 |
| US-20210401946-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | CYP2D6 1736/4885THRB 974/4885HSD17B10 2189/4885 |
| US-20210386693-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | APP, PSEN1, PSEN2 | CYP2D6 602/4885THRB 4606/4885HSD17B10 1487/4885 |
| US-20210401947-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | CYP2D6 1736/4885THRB 974/4885HSD17B10 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.